Showing results (71-80 of 152) with videos related to
Sort By:
Pageof 16
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 31, 2008
The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosisHideyuki Eto, Masaaki Miyata, Takahiro Shirasawa, et al.Journal of Cardiology|October 2, 2010
Improvement of autonomic nervous activity by Waon therapy in patients with chronic heart failureSo Kuwahata, Masaaki Miyata, Shoji Fujita, et al.Journal of Atherosclerosis and Thrombosis|September 1, 2017
Prospective Study on the Incidence of Cerebrovascular Disease After Coronary AngiographyAkihiro Tokushige, Masaaki Miyata, Takeshi Sonoda, et al.Journal of Cardiology|May 2, 2016
Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillationAkino Yoshimura, Yasuhisa Iriki, Hitoshi Ichiki, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|March 28, 2006
Repeated thermal therapy up-regulates endothelial nitric oxide synthase and augments angiogenesis in a mouse model of hindlimb ischemiaYuichi Akasaki, Masaaki Miyata, Hideyuki Eto, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|November 8, 2016
Uric Acid Level and Prevalence of Atrial Fibrillation in a Japanese General Population of 285,882Shin Kawasoe, Takuro Kubozono, Shiro Yoshifuku, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 19, 2025
Risk prediction score and equation for progression of arterial stiffness using Japanese longitudinal health examination dataNaoko Inadome, Shin Kawasoe, Masaaki Miyata, et al.Drug Metabolism and Pharmacokinetics|September 2, 2006
Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferaseMasaaki Miyata, Yoshiki Matsuda, Hiroyuki Tsuchiya, et al.Journal of Cardiology|February 22, 2011
Identification of novel mutations in the α-galactosidase A gene in patients with Fabry disease: pitfalls of mutation analyses in patients with low α-galactosidase A activityMakoto Yoshimitsu, Koji Higuchi, Masaaki Miyata, et al.European Journal of Pharmacology|July 27, 2007
ME3738 protects against lithocholic acid-induced hepatotoxicity, which is associated with enhancement of biliary bile acid and cholesterol outputMasahiro Nomoto, Masaaki Miyata, Miki Shimada, et al.Pageof 16